OCT 13, 2020 5:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Lifting the Veil on Innovations and Product Launches 2020

Sponsored by: Bruker Daltonics
Speaker
  • Senior Vice President R&D, Regulatory and Scientific Affairs Bruker DALTONICS Microbiology & Diagnostics
    Biography
      Dr. Markus Kostrzewa joined Bruker in 1998 as Head of the new R&D group “Bioanalytical Development“, establishing molecular biology and biology related development at Bruker Daltonik GmbH. The initial focus went to development of DNA analysis methods by MALDI-TOF mass spectrometry, and “Clinical Proteomics”, the latter covering methods, consumables and software for mass spectrometry profiling of body fluids and tissues.
      His R&D group progressed to successful development of microorganism identification by Bruker’s MALDI-TOF mass spectrometry, today globally known as the “MALDI Biotyper®” system.
      Dr. Kostrzewa became Director Molecular Biology R&D in 2005, got promoted to Vice President Clinical Mass Spectrometry R&D in 2012, which was broadened to Vice President Microbiology & Diagnostics R&D in 2017.
      Since 2019, Dr. Kostrzewa is Bruker’s Senior Vice President Microbiology & Diagnostics R&D, Regulatory and Scientific Affairs, heading innovation at Bruker Microbiology and Diagnostics. This includes strategic planning of innovative products and driving regulatory approval processes (IVD-CE labelling, FDA clearance, ISO/AOAC certification for Food market).

    Abstract
    Date:  October 13, 2020
    Time: 5:00am (PDT),  8:00am (EDT),  2:00 pm (CEST)
     
    Dr. Markus Kostrzewa shall elaborate the progress that has been made in Bruker Microbiology & Diagnostics (M&D) Research and Development, including new product launches as well as improvements of existing systems. Also, provisional results of some ongoing innovation projects and studies will be reported. The topics will cover the whole area of Bruker M&D R&D, including MALDI Biotyper®, IR Biotyper®, susceptibility testing and PCR technology.
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    MAY 12, 2020 9:00 AM PDT
    C.E. CREDITS
    MAY 12, 2020 9:00 AM PDT
    NEW DATE: Date: May 12, 2020 Time: 9:00am PDT, 12:00pm EDT...
    JUN 30, 2020 9:00 AM PDT
    C.E. CREDITS
    JUN 30, 2020 9:00 AM PDT
    DATE: June 30, 2020 TIME: 9:00am PDT, 12:00pm EDT QC laboratories perform a critical role in demonstrating pharmaceutical products are consistently manufactured, safe, potent, and pure. At t...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds
    Attendees
    • See more